<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0300-9041</journal-id>
<journal-title><![CDATA[Ginecología y obstetricia de México]]></journal-title>
<abbrev-journal-title><![CDATA[Ginecol. obstet. Méx.]]></abbrev-journal-title>
<issn>0300-9041</issn>
<publisher>
<publisher-name><![CDATA[Federación Mexicana de Colegios de Obstetricia y Ginecología A.C.]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0300-90412019000800006</article-id>
<article-id pub-id-type="doi">10.24245/gom.v87i8.3143</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Micrometástasis ganglionares en pacientes con cáncer ginecológico. Serie de casos y revisión de la bibliografía]]></article-title>
<article-title xml:lang="en"><![CDATA[Nodal micrometastasis in gynecological cancer patients. Case series and literature review]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Valdespino-Castillo]]></surname>
<given-names><![CDATA[Víctor Edmundo]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Mendoza-Ramón]]></surname>
<given-names><![CDATA[Hilda]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Maytorena-Córdova]]></surname>
<given-names><![CDATA[Germán]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Ferrer-Torres]]></surname>
<given-names><![CDATA[Paola]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[López-Matamoros]]></surname>
<given-names><![CDATA[Israel]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Valdespino-Gómez]]></surname>
<given-names><![CDATA[Víctor]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Instituto Mexicano del Seguro Social Hospital de Ginecoobstetricia Dr. Luis Castelazo Ayala ]]></institution>
<addr-line><![CDATA[Ciudad de México ]]></addr-line>
<country>Mexico</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Instituto Mexicano del Seguro Social Hospital de Ginecoobstetricia Dr. Luis Castelazo Ayala ]]></institution>
<addr-line><![CDATA[Ciudad de México ]]></addr-line>
<country>Mexico</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,Instituto Mexicano del Seguro Social Hospital de Ginecoobstetricia Dr. Luis Castelazo Ayala ]]></institution>
<addr-line><![CDATA[Ciudad de México ]]></addr-line>
<country>Mexico</country>
</aff>
<aff id="Af4">
<institution><![CDATA[,Instituto Mexicano del Seguro Social Hospital de Ginecoobstetricia Dr. Luis Castelazo Ayala ]]></institution>
<addr-line><![CDATA[Ciudad de México ]]></addr-line>
<country>Mexico</country>
</aff>
<aff id="Af5">
<institution><![CDATA[,Instituto Mexicano del Seguro Social Hospital de Ginecoobstetricia Dr. Luis Castelazo Ayala ]]></institution>
<addr-line><![CDATA[Ciudad de México ]]></addr-line>
<country>Mexico</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>00</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>00</month>
<year>2019</year>
</pub-date>
<volume>87</volume>
<numero>8</numero>
<fpage>527</fpage>
<lpage>534</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_arttext&amp;pid=S0300-90412019000800006&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_abstract&amp;pid=S0300-90412019000800006&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_pdf&amp;pid=S0300-90412019000800006&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen  OBJETIVO:  Identificar micrometástasis ganglionares en neoplasias malignas ginecológicas, y las características histopatológicas y clínicas asociadas con los hallazgos.  MATERIALES Y MÉTODOS:  Estudio observacional, descriptivo y retrospectivo efectuado en pacientes con uno o más ganglios con micrometástasis identificados en cirugías primarias etapificadoras por cáncer de endometrio, ovario o cervicouterino, linfadenectomía sistemática o ganglio centinela, atendidas en el Hospital de Ginecoobstetricia Dr. Luis Castelazo Ayala, de enero de 2014 a diciembre de 2018. Criterios de exclusión: ausencia micrometástasis ganglionares. Criterios de eliminación: información incompleta en el expediente clínico, sin seguimiento y falta de evidencia patológica de micrometástasis ganglionar. Variables de estudio: identificación de ganglios con micrometástasis, diagnóstico de cáncer ginecológico por tratamiento quirúrgico y tasa de supervivencia. Para la revisión bibliográfica se consultó la base de datos de PubMed, con MeSH o palabras clave: &#8220;micrometástasis ganglionares&#8221; y &#8220;cáncer de ovario&#8221;; &#8220;cáncer de endometrio&#8221;, &#8220;cáncer cervicouterino&#8221; y &#8220;cáncer ginecológico con micrometástasis&#8221;.  RESULTADOS:  Se registraron 11 casos de micrometástasis ganglionares, de un total de 433 con cáncer de ovario, endometrio o cervicouterino. No se aplicaron pruebas estadísticas por lo limitado de la muestra. En todos los casos se identificó, mínimo, un ganglio con micrometástasis, con ganglio centinela o linfadenectomía sistemática. Todas las pacientes recibieron tratamiento coadyuvante.  CONCLUSIONES:  Es importante efectuar la identificación de micrometástasis en linfadenectomías sistemáticas mediante la tinción con hematoxilina-eosina (es la metodología más accesible y económica para el sistema público de salud de México) o búsqueda de ganglio centinela, con la finalidad de determinar la frecuencia en población mexicana y establecer la etapa patológica real de la enfermedad.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract  OBJECTIVE:  To identify lymph node micrometastases in malignant gynecological neoplasms and their histopathological and clinical characteristics associated with the findings.  MATERIALS AND METHODS:  Observational, descriptive and retrospective study performed in patients with one or more lymph nodes with micrometastases in primary stage surgery for endometrial, ovarian or cervical cancer, systematic lymphadenectomy or sentinel node, attended at the Hospital de Ginecoobstetricia 4 Dr. Luis Castelazo Ayala, from January 2014 to December 2018. Exclusion criteria: no ganglion micrometastases. Elimination criteria: incomplete information in the clinical file, without follow-up and lack of pathological evidence of lymph node micrometastasis. The variables to be considered were: identification of lymph nodes with micrometastases, diagnosis of gynecological cancer by surgical treatment and survival rate. For the literature review, the PubMed database was consulted, with key words such as &#8220;ganglionic micrometastases&#8221; and &#8220;ovarian cancer&#8221;, &#8220;endometrial cancer&#8221;, &#8220;cervical cancer&#8221; and &#8220;gynecological cancer with micrometastasis&#8221;.  RESULTS:  There were 11 cases of lymph node micrometastases, of a total of 433 with ovarian, endometrial or cervical cancer. No statistical tests were applied because of the limited sample. In all cases, a lymph node with micrometastasis, with a sentinel lymph node or systematic lymphadenectomy was identified. All patients received coadjuvant treatment.  CONCLUSIONS:  It is important to identify micrometastases in systematic lymphadenectomy by staining with haematoxylin-eosin (the most accessible and economical methodology for the public health system in Mexico) or sentinel lymph node search, in order to determine the frequency in the Mexican population and establish the actual pathological stage of the disease.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Micrometástasis ganglionares]]></kwd>
<kwd lng="es"><![CDATA[cáncer ginecológico]]></kwd>
<kwd lng="es"><![CDATA[cáncer de ovario]]></kwd>
<kwd lng="es"><![CDATA[linfadenectomía]]></kwd>
<kwd lng="en"><![CDATA[Lymph node micrometastasis]]></kwd>
<kwd lng="en"><![CDATA[Gynecological cancer]]></kwd>
<kwd lng="en"><![CDATA[Ovarian cancer]]></kwd>
<kwd lng="en"><![CDATA[Lymphadenectomy]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lentz]]></surname>
<given-names><![CDATA[SE]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Identification of micrometastases in histologically negative lymph nodes of early-stage cervical cancer patients]]></article-title>
<source><![CDATA[Obstet Gynecol]]></source>
<year>2004</year>
<volume>103</volume>
<page-range>1204-10</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Marchiolé]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Clinical significance of lympho vascular space involvement and lymph node micrometastases in early-stage cervical cancer: a retrospective case-control surgico- pathological study]]></article-title>
<source><![CDATA[Gynecol Oncol]]></source>
<year>2005</year>
<volume>97</volume>
<page-range>727-32</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Edge]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<source><![CDATA[AJCC Cancer Staging Manual]]></source>
<year>2010</year>
<edition>7th ed</edition>
<publisher-loc><![CDATA[Philadelphia ]]></publisher-loc>
<publisher-name><![CDATA[Lippincott Raven]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Clinton]]></surname>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Low-Volume Lymph Node Metastases in Endometrial Carcinoma]]></article-title>
<source><![CDATA[Int J Gynecol Cancer]]></source>
<year>2017</year>
<volume>27</volume>
<page-range>1165-70</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[St Clair]]></surname>
<given-names><![CDATA[CM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Low-volume lymph node metastasis discovered during sentinel lymph node maping for endometrial carcinoma]]></article-title>
<source><![CDATA[Ann Surg Oncol]]></source>
<year>2016</year>
<volume>23</volume>
<page-range>1653-9</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bhatla]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Cancer of the cervix uteri]]></article-title>
<source><![CDATA[Int J Gyencol Obstet]]></source>
<year>2018</year>
<volume>143</volume>
<page-range>22-36</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kim]]></surname>
<given-names><![CDATA[CH]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Pathologic ultrastaging improves micrometastasis detection in sentinel lymph nodes during endometrial cancer staging]]></article-title>
<source><![CDATA[Int J Gynecol Cancer]]></source>
<year>2013</year>
<volume>23</volume>
<page-range>964-70</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Stany]]></surname>
<given-names><![CDATA[MP]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Lymph Node Micrometastases in Early-Stage Cervical Cancer are Not Predictive of Survival]]></article-title>
<source><![CDATA[Int J Gynecol Pathol]]></source>
<year>2015</year>
<volume>34</volume>
<page-range>379-84</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Piedimonte]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Clinical significance of isolated tumor cells and micrometastasis in low-grade, stage I endometrial cancer]]></article-title>
<source><![CDATA[J Surg Oncol]]></source>
<year>2018</year>
<page-range>1-5</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Clinton]]></surname>
<given-names><![CDATA[LK]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Low-volume lymph node metastases in endometrial carcinoma]]></article-title>
<source><![CDATA[Int J of Gynecol Cancer]]></source>
<year>2017</year>
<volume>27</volume>
<page-range>1165-70</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Yasunaga]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Endometrial carcinomas with lymph node involvement: novel histopathologic factors for predicting prognosis]]></article-title>
<source><![CDATA[Int J Gynecol Pathol]]></source>
<year>2003</year>
<volume>22</volume>
<page-range>341-6</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Tang]]></surname>
<given-names><![CDATA[X]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Clinicopathological factors predicting retroperito- neal lymph node metastasis and survival in endometrial cancer]]></article-title>
<source><![CDATA[Jpn J Clin Oncol]]></source>
<year>1998</year>
<volume>28</volume>
<page-range>673-8</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Valdespino]]></surname>
<given-names><![CDATA[VE]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Two cases dysgerminoma with micrometastasis in lymph nodes]]></article-title>
<source><![CDATA[Obstet Gynecol Int J]]></source>
<year>2019</year>
<volume>10</volume>
<page-range>31-4</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pentheroudakis]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Carmeliet]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Bevacizumab and micrometastases: Revisiting the preclinical and clinical rollercoaster]]></article-title>
<source><![CDATA[Pharmacol Ther]]></source>
<year>2014</year>
<volume>141</volume>
<page-range>117-24</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cress]]></surname>
<given-names><![CDATA[RD]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Surgical staging of early stage epithelial ovarian cancer: results from the CDC-NPCR ovarian patterns of care study]]></article-title>
<source><![CDATA[Gynecol Oncol]]></source>
<year>2011</year>
<volume>121</volume>
<page-range>94-9</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Nomura]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Lymph node metastasis in grossy apparent stages I and II epithelial ovarian cancer]]></article-title>
<source><![CDATA[Int J Gynecol Cancer]]></source>
<year>2010</year>
<volume>3</volume>
<page-range>341-5</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Benedetti]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Pelvic and aortic lymphadenectomy in cervical cancer: The standardization of surgical procedure and its clinical impact]]></article-title>
<source><![CDATA[Gynecol Oncol]]></source>
<year>2009</year>
<volume>113</volume>
<page-range>284-90</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cibula]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prognostic significance of low volume sentinel lymph node disease in early-stage cervical cancer]]></article-title>
<source><![CDATA[Gynecol Oncol]]></source>
<year>2012</year>
<volume>124</volume>
<page-range>496-501</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Peters]]></surname>
<given-names><![CDATA[WA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix]]></article-title>
<source><![CDATA[J Clin Oncol]]></source>
<year>2000</year>
<volume>18</volume>
<page-range>1606-13</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Delgado]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prospective surgical-pathologic study of disease-free interval in patients with stage IB squamous carcinoma of the cervix: a Gynecologic Oncology Group study]]></article-title>
<source><![CDATA[Gynecol Oncol]]></source>
<year>1990</year>
<volume>38</volume>
<page-range>352-7</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Colturato]]></surname>
<given-names><![CDATA[LF]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Lymph node micrometastases in initial stage cervical cancer and tumoral recurrence]]></article-title>
<source><![CDATA[Int J Gynecol Obstet]]></source>
<year>2016</year>
<volume>133</volume>
<page-range>69-75</page-range></nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Guani]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Impact of micrometastasis or isolated tumor cells on recurrence and survival in patients with early cervical cancer. SENTICOL Trial]]></article-title>
<source><![CDATA[Int J Gynecol Cancer]]></source>
<year>2019</year>
<volume>29</volume>
<page-range>447-52</page-range></nlm-citation>
</ref>
<ref id="B23">
<label>23</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Le Guelte]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Jumping the barrier: VE-cadherin, VEGF and other angiogenic modifiers in cancer]]></article-title>
<source><![CDATA[Biol Cell]]></source>
<year>2011</year>
<volume>103</volume>
<page-range>593-605</page-range></nlm-citation>
</ref>
<ref id="B24">
<label>24</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Greenberg]]></surname>
<given-names><![CDATA[JI]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[VEGF as an inhibitor of tumor vessel maturation: implications for cancer therapy]]></article-title>
<source><![CDATA[Expert Opin Biol Ther]]></source>
<year>2009</year>
<volume>9</volume>
<page-range>1347-56</page-range></nlm-citation>
</ref>
<ref id="B25">
<label>25</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Valdespino]]></surname>
<given-names><![CDATA[CV]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Resección ganglionar retroperitoneal en cáncr ginecológico: utilidad como biomarcador predictivo]]></article-title>
<source><![CDATA[Ginecol Obstet Mex]]></source>
<year>2018</year>
<volume>86</volume>
<page-range>464-77</page-range></nlm-citation>
</ref>
<ref id="B26">
<label>26</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cibula]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Risk of micrometastases in non-sentinel pelvic lymph nodes in cervical cancer]]></article-title>
<source><![CDATA[Gynecol Oncol]]></source>
<year>2016</year>
<volume>143</volume>
<page-range>83-6</page-range></nlm-citation>
</ref>
<ref id="B27">
<label>27</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kitchener]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Swart]]></surname>
<given-names><![CDATA[AM]]></given-names>
</name>
<name>
<surname><![CDATA[Qian]]></surname>
<given-names><![CDATA[Q]]></given-names>
</name>
<name>
<surname><![CDATA[Amos]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Parmar]]></surname>
<given-names><![CDATA[MK]]></given-names>
</name>
</person-group>
<collab>ASTEC study group</collab>
<article-title xml:lang=""><![CDATA[Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study]]></article-title>
<source><![CDATA[Lancet]]></source>
<year>2009</year>
<volume>373</volume>
<page-range>125-36</page-range></nlm-citation>
</ref>
<ref id="B28">
<label>28</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Barlin]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Classification and Regression Tree (CART) Analysis of Endometrial Carcinoma: Seeing the Forest for the Trees]]></article-title>
<source><![CDATA[Gynecol Oncol]]></source>
<year>2013</year>
<volume>130</volume>
<page-range>452-6</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
